The goal of our research group is to understand the biological mechanisms underlying the initiation and progression of malignant tumors, and to identify and characterize novel molecular targets that may be used for future development of targeted therapies, including cell and gene therapy. Our laboratory carries out basic and pre-clinical research with a strong translational profile. Our ultimate goal is to generate deliverables that can be tested in the clinical setting.
Please visit the lab pages for updated research information:
Martha Enger lab - brain tumour immunology and therapy
Thorsen lab - brain metastasis
Miletic lab - gene therapy for glioblastoma
Per Øyvind Enger lab